Rumiko Okamoto - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Rumiko Okamoto

Showing results (21-30 of 26) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 26 results.

The New England Journal of Medicine|March 5, 2015

Bortezomib-based therapy for newly diagnosed mantle-cell lymphomaTadeusz Robak, Huiqiang Huang, Jie Jin, et al.

Cancer Science|November 3, 2011

Central nervous system event in patients with diffuse large B-cell lymphoma in the rituximab eraNaoto Tomita, Masahiro Yokoyama, Wataru Yamamoto, et al.

Leukemia & Lymphoma|June 9, 2017

The standard international prognostic index for predicting the risk of CNS involvement in DLBCL without specific prophylaxisNaoto Tomita, Masahiro Yokoyama, Wataru Yamamoto, et al.

International Journal of Hematology|March 4, 2010

Prognostic analysis and a new risk model for Hodgkin lymphoma in JapanKuniaki Itoh, Tomohiro Kinoshita, Takashi Watanabe, et al.

Journal of Hepatology|March 21, 2020

Ultra-high sensitivity HBsAg assay can diagnose HBV reactivation following rituximab-based therapy in patients with lymphomaShigeru Kusumoto, Yasuhito Tanaka, Ritsuro Suzuki, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 4, 2015

Monitoring of Hepatitis B Virus (HBV) DNA and Risk of HBV Reactivation in B-Cell Lymphoma: A Prospective Observational StudyShigeru Kusumoto, Yasuhito Tanaka, Ritsuro Suzuki, et al.

Pageof 3

Search research articles

Showing results (21-30 of 26) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 26 results.

The New England Journal of Medicine|March 5, 2015

Bortezomib-based therapy for newly diagnosed mantle-cell lymphomaTadeusz Robak, Huiqiang Huang, Jie Jin, et al.

Cancer Science|November 3, 2011

Central nervous system event in patients with diffuse large B-cell lymphoma in the rituximab eraNaoto Tomita, Masahiro Yokoyama, Wataru Yamamoto, et al.

Leukemia & Lymphoma|June 9, 2017

The standard international prognostic index for predicting the risk of CNS involvement in DLBCL without specific prophylaxisNaoto Tomita, Masahiro Yokoyama, Wataru Yamamoto, et al.

International Journal of Hematology|March 4, 2010

Prognostic analysis and a new risk model for Hodgkin lymphoma in JapanKuniaki Itoh, Tomohiro Kinoshita, Takashi Watanabe, et al.

Journal of Hepatology|March 21, 2020

Ultra-high sensitivity HBsAg assay can diagnose HBV reactivation following rituximab-based therapy in patients with lymphomaShigeru Kusumoto, Yasuhito Tanaka, Ritsuro Suzuki, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 4, 2015

Monitoring of Hepatitis B Virus (HBV) DNA and Risk of HBV Reactivation in B-Cell Lymphoma: A Prospective Observational StudyShigeru Kusumoto, Yasuhito Tanaka, Ritsuro Suzuki, et al.

Pageof 3